Spironolactone lowers adrenal androstenedione levels by inhibiting 17α-hydroxylase and 17,20-lyase, and reduces DHEA-sulfate levels by inhibiting 3β-hydroxysteroid dehydrogenase. Its primary mechanisms of action are the blockade of androgen receptors and the inhibition of 5α-reductase, as well...